The Nasdaq trades at 27.5 times analysts’ expected aggregate earnings for the coming 12 months for companies on the index, near the highest level in the past two years.
From hushed whispers in market stalls to bold online advertisements, the demand and conversation around aphrodisiacs, popularly known as sex enhancers, have taken a new dimension.